No significant risk of new diabetes onset after pancreatectomy for PCLs: ACG 2020
Columbus, OH: The risk of new onset diabetes mellitus (NODM) after partial pancreatectomy for pancreatic cystic lesions (PCLs) is not excessive and is relatively higher in older patients with features of cardiovascular disease and/or metabolic syndrome.
The findings of the study were presented at the ACG 2020 Virtual Annual Scientific Meeting.
People undergoing pancreatic resection have a risk of developing post-operative NODM. Patients with PCLs generally have normal adjacent pancreatic parenchyma compared with patients who undergo surgery for other indications including pancreatic adenocarcinoma, and acute and chronic pancreatitis. However, postoperative diabetes risk among PCLs patients is poorly defined. Therefore, the objective of the study by Stephen Firkins, The Ohio State University Wexner Medical Center, Columbus, OH, and colleagues, was to characterize the risk factors and incidence associated with NODM following pancreatectomy for PCLs.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.